Get the Stockscreener App
12.76
3.57%
0.44
After Hours:
12.76
Electrocore Inc stock is traded at $12.76, with a volume of 74,884.
It is up +3.57% in the last 24 hours and up +73.61% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$12.32
Open:
$12.48
24h Volume:
74,884
Relative Volume:
1.70
Market Cap:
$79.94M
Revenue:
$16.03M
Net Income/Loss:
$-18.83M
P/E Ratio:
-2.7203
EPS:
-4.6906
Net Cash Flow:
$-14.87M
1W Performance:
+14.95%
1M Performance:
+73.61%
6M Performance:
+101.74%
1Y Performance:
+106.47%
1-Day Range:
$12.25
$12.90
1-Week Range:
$10.96
$12.90
52-Week Range:
$5.02
$12.90
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
ElectroCore stock soars to 52-week high, hits $12.03 - Investing.com
ElectroCore stock soars to 52-week high, hits $12.03 By Investing.com - Investing.com UK
electroCore (NASDAQ:ECOR) Trading 1.1% Higher – What’s Next? - Defense World
electroCore, Inc. (NASDAQ:ECOR) Shares Purchased by International Assets Investment Management LLC - MarketBeat
electroCore (NASDAQ:ECOR) Trading Up 1.1%Time to Buy? - MarketBeat
Insiders Rewarded With US$488k Addition To Investment As electroCore Stock Hits US$73m - Simply Wall St
ElectroCore stock soars to 52-week high, hits $10.31 - Investing.com
ElectroCore stock soars to 52-week high, hits $10.31 By Investing.com - Investing.com UK
electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024 - GlobeNewswire
ElectroCore, Inc. (ECOR): A Bull Case Theory - Insider Monkey
ElectroCorePioneering The Neurological Landscape Of Well-Being With NVNS - RTTNews
electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar? - MSN
Digital Migraine Treatment Device Market Analysis: Segments, - openPR
ElectroCore stock soars to 52-week high of $8.19 - Investing.com
ElectroCore stock soars to 52-week high of $8.19 By Investing.com - Investing.com UK
electroCore to Participate at LD Micro Main Event VXII - Midnorth Monitor
ElectroCore stock soars to 52-week high, hits $8.09 By Investing.com - Investing.com South Africa
electroCore Inc (ECOR) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
ElectroCore stock soars to 52-week high, hits $8.09 - Investing.com
Investors in electroCore (NASDAQ:ECOR) have unfortunately lost 72% over the last five years - Yahoo Finance
electroCore, Inc. (NASDAQ:ECOR) Soars 34% But It's A Story Of Risk Vs Reward - Simply Wall St
Vagus Nerve Stimulation Devices Market is Expected to Reach US$ 43.33 Bn by the End of 2031-LivaNova, Enteromedics, ElectroCore, BioControl – cineglit - Cineglit
electroCore to Participate in Upcoming Investor Conferences - The Manila Times
Vagus Nerve Stimulators Market Outlook by Examining the Results - openPR
electroCore (NASDAQ:ECOR) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey - Defense World
We Think electroCore (NASDAQ:ECOR) Can Afford To Drive Business Growth - Simply Wall St
electroCore Engages FNK IR to Execute Expanded Investor Relations Program - GlobeNewswire
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) - GlobeNewswire
Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training - StockTitan
Vagus Nerve Stimulators Market Report, Size, Share & Outlook - openPR
ElectroCore Announces CFO Transition and Shareholder Meeting Outcomes - TipRanks
electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
electroCore, Inc. (NASDAQ:ECOR) Short Interest Up 20.1% in August - Defense World
Vagus Nerve Stimulators Industry to Witness Massive Growth - openPR
electroCore, Inc. (NASDAQ:ECOR) Director Thomas J. Errico Buys 5,000 Shares of Stock - Defense World
ElectroCORE Debuts TAC-STIM - MPO-mag
electroCORE Debuts TAC-STIM - MPO-mag
Q3 2024 EPS Estimates for electroCore, Inc. Increased by Brookline Capital Management (NASDAQ:ECOR) - Defense World
electroCore Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript - Seeking Alpha
ECORelectroCore, Inc. Latest Stock News & Market Updates - StockTitan
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Electrocore Inc Stock (ECOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GANDOLFO JOHN P | Director |
Jun 13 '24 |
Buy |
6.43 |
1,000 |
6,430 |
50,704 |
| Goldberger Daniel S | Chief Executive Officer |
Jun 05 '24 |
Buy |
6.43 |
38,505 |
247,587 |
249,565 |
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):